The company is based on values that are very dear to us, namely highly attentive customer care, quality products, as well as innovation, and on its collaboration with many key opinion leaders in the dentistry field.
Both a pioneer and a leader, Panthera Dental has successfully combined creativity, science and know-how to develop its proprietary innovative technology and is now able to offer next-generation products to the dental industry worldwide.
Gabriel Robichaud leads the strategic direction and the overall development of the company.
He graduated from Laval University in Business Administration and from Cégep de Lévis-Lauzon in Industrial Robotics. He then followed additional training programs in management, including one in Project Management at École de technologie supérieure (ÉTS).
Béatrice Robichaud is responsible for new product launches, product introduction at the international level, and customer technical support.
She is the co-founder of Panthera Dental, a lecturer, and a Specialist in High Technology CAD/CAM Dental Products. She graduated in Telecommunications at Collège radio télévision de Québec (CRTQ). During her career, she led several lectures in English and French in 10 different countries and trained over 400 dental specialists in the CAD/CAM dental field.
David “Kim” Solomon is responsible for sales, marketing, and brand development for Panthera Dental in the United States. He is a sales and marketing executive with expertise in business development, product launch, CAD/CAM digital technology, and clinical/restorative solutions. He is specialized in both direct and distributor sales channels with focus on B2B and B2C. Through the years, Kim has built sales and marketing teams for public and private dental companies in the clinical/restorative, medical device, and laboratory service industries.
Kyle Steadman is a seasoned manager with over 15 years of experience in financial management, controlling, planning and corporate development activities. He is responsible for Panthera Dental’s overall financial management, including the company’s financial reporting, long-range business planning, treasury and internal controls and he is an active participant in corporate development. Kyle has gained growing experience in international corporate activities working in both public and private Med-Tech companies on various projects including computer system migrations, internal control system set-up and surveillance, international taxation and change management..
Graduated from McGill University, Don Murray is a senior technology business development manager with 25 years of multinational B2B experience. He is in charge of Panthera Dental’s business relations and corporate development for all Panthera products. Don Murray has a successful track record in corporate-wide change management, international business development, sales channel management, product development & manufacturing ramp-up including after-sales service for complex products and systems. He is multilingual with field experience in the United-States, Europe, Brazil, Japan and China.
Jean-Pierre Desmarais is the CEO of Innovitech Inc., an innovation expert firm in the field of Medical Technologies and Aerospatiale.
Jean-Pierre has more than 40 years’ experience in the medical device industry from large multinational to small startups and a vast expertise in Medical Technology from inception to commercialization; from early R&D, pre-clinical and clinical research, commercial approval globally; inclusive of USFDA, EU CE Australia, Japan; global reimbursement programs and early strategic commercialization globally.
He served as President of Piramal Healthcare Bio-Orthopedics, a spin off from Montréal engineering school École Polytechnique, in the field of cartilage repair, that resulted into the technology acquisition in 2016 by Smith+Nephew, an orthopedic giant company. Prior to Piramal, Jean-Pierre worked at CryoCath Technologies as the Chief Scientific Officer in the field of cardiac electrophysiology. This Canadian technology startup from Montréal, founded in 1995 and acquired in 2008 by Medtronic USA for 400M$., treated more than 350,000 individuals around the world and had a profound healthcare and quality of life impact in the lives of people suffering from of Atrial Fibrillation.
Jean-Pierre also served as Interim General Manager MDCC in 2016, a Medical Device Commercialization Center from the Federal Government National Centre of Excellence. Jean-Pierre holds a B.Sc. in Microbiology from Sherbrooke University, Canada and has served on several Boards of Medical Devices trade associations such as MEDEC Canada, MedTeQ as well as medical devices startup companies such as Hexoskin (connected health wearables), Biorthex (a spine company), Cardianove (an LVAD cardiology company), CyBiocare (a diabetes company) and BioSyntech (orthopedics) acquired by Piramal in 2010.
Gabriel Robichaud is a senior executive with more than 15 years of experience in operations management for medtech companies with an emphasis on personalized medicine. He has been instrumental in the launch of several start-up companies that reached sustainable growth and great success. These success stories have been achieved through his fresh vision, leadership, and strong sense of innovation. Gabriel draws on a creative and strategic approach to solve issues and manage effectively. Since the beginning of his career, he has often played a leading role in product development and recruitment to build high-performing teams.
Diane Robichaud is Laboratory Director at Panthera Dental and a member of the research and development team working on mandibular advancement devices for the treatment of snoring and obstructive sleep apnea. Having worked in the field of dentistry for more than 30 years, Diane is a member of the Ordre des techniciens et techniciennes dentaires du Québec and holds a laboratory management permit. She received two awards for the excellence of her work and co-founded a dental laboratory that she subsequently sold to dedicate herself to sleep problems at Panthera. Holder of a certificate in accounting sciences from Laval University, the daily management, administration and development of a SME brought her experience in different administration and management activity sectors. She is passionate about healthy sleep.
Nicola Urbani has more than 15 years of experience in venture capital investments, primarily in life sciences and cleantech, with two different venture capital groups: GeneChem Management and CIC Capital Ventures. Dr. Urbani has served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Dr. Urbani has had an active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier International and Canadian venture capital funds. Prior to joining CIC Capital Ventures, Dr. Urbani was the VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and creating start-up companies. Dr. Urbani received his Ph. D in molecular genetics from McGill University and his MBA from Université du Québec à Montréal.
Dr. Marengère is a Managing Partner with TVM Capital Life Sciences. Luc has overseen the implementation of the Canadian operations and the North American investment strategy. Also, Luc co-manages the relationship with strategic partner Eli Lilly.
Dr. Marengère has joined TVM LSV VII in 2011 and has more than 20 years of venture capital experience. Luc oversaw a number of investments on behalf of TVM LSV VII and is a Director on the Boards of Ixchelsis Ltd (UK); PRCL Pharma (Canada); Aurka Pharma (Canada); Panthera Dental Inc. (Canada); FAAH Pharma (Canada); Kaneq Biosciences (Canada), Acer Therapeutics (USA); TeserX Pharma (USA). Luc was a Director on the Board of Colucid Pharma (USA) sold to Eli Lilly in March 2017 for US$960M.
Prior to joining TVM Capital, Luc was a Managing General Partner with VG Partners where he founded and ran the VG Advanced Life Sciences Fund (VG ALSF – CDN$230M). Luc was a Director on the Boards of Trillium Technologies Inc. (NASDAQ listed); Cytochroma Inc., (Sold to Opko for US$400M); Aegera Therapeutics Inc. (Sold to Pharmascience Ltd); Cita Neuropharma (sold to Vernalis Plc for US$85M) and lastly Argos Therapeutics Inc., (NASDAQ listed). Luc also invested in VisualSonics Inc. (sold to Sonosite for US$75M).
Prior to joining VG Partners, Luc focused on making venture investments in the life science sector while with La Caisse De Dépôt’s venture arm SOFINOV and MDS Capital Corp. Prior to his venture capital career, he conducted commercially-oriented research in the fields of immunology and oncology while at Amgen. Luc holds a Ph.D. from University of Toronto’s department of Medical Biophysics and Molecular Genetics.
Building on his experience in management and marketing, Louis-Philippe Rochefort has joined Panthera Dental in 2013 as Director of Business Development. Since January 2014, Louis-Philippe has been holding the position of Regional Sales Director for Eastern Canada. He has a very extensive experience in the dental field and can easily identify the needs of the customers to fulfill their requirements.
Andreas is a Registered Dental Technologist with over 30 years of experience in the dental field. Andreas graduated from Technikon School of Dental Technology in South Africa in 1986. He founded La Lucia Dental Laboratory in 1991 and operated it until he came to Canada in 2001. In 2005, he became an RDT in Ontario. Andreas plays a major role in Panthera Dental’s strategy to incorporate more technical guides and articles into its portfolio. His experience as a dental technologist, combined with his field experience, allows him to offer customers precise and detailed solutions on a more technical level.
Tony Pacheco is the Director of Sales for the Great Lakes Region, covering 11 states from Michigan to the Dakotas. Tony attended Central Michigan University and has over 10 years in specialty product sales, with the last four as a top performer for a major dental manufacturer. Tony has a strong “customer first” attitude and thrives on helping dental lab owners find solutions to better serve their clientele and ultimately the patient.
Kevin McAndrews is a third-generation dental lab professional with more than 30 years of experience in implant dentistry, laboratory operations, sales, and marketing. He received his Associate’s degree in Applied Science to Dental Technology, a Bachelor’s Degree in Business Management, and obtained additional certifications for advanced studies in implant and esthetic dentistry. Kevin is known for successfully managing some of the largest labs in North America as well as running his own operation. He continues his passion for dental technology and supporting laboratories to thrive in today’s market.
Beginning her career in 1991, Stacey Kiel quickly rose through the ranks in the dental sales field. She worked as a clinical chairside, dental lab technician and laboratory manager. Stacey also owned two dental assistant training schools in Illinois where she trained chairside dental assistants and helped dental professionals find adequate staff. In addition to her presentation skills, Stacey Kiel is outstanding at training and building customer relationship.
Of German education, once his dental technician diploma in hand, Christophe Paulé chose to focus on the dental industry in business development. His deep knowledge of this field and multiple training courses offered him numerous international career opportunities within major companies where he served successively as a Product Specialist CAD/CAM, Area Sales Manager, and Key Account Manager. Christophe likes to say today that he is in the right place at the right time!